Mr. Sanat Chattopadhyay is Executive Vice President and President of the Merck Manufacturing Division, with responsibility for Merck & Co. worldwide manufacturing operations. He oversees a network of pharmaceuticals, vaccines, biologics/therapeutic proteins and animal health manufacturing and distribution sites with approximately 16,500 employees in over 22 countries around the world. Mr. Chattopadhyay serves as a member of Merck’s Executive Committee.
He has a proven senior leadership track record of commercialization, manufacturing and supply chain excellence in therapeutic proteins, vaccines and pharmaceuticals for Hoechst, Aventis, Wyeth and Merck for more than 30 years.
Before joining Merck in November 2009, Sanat worked for Wyeth Pharmaceuticals as Senior Vice President, New Products & Process Development. A graduate Chemical Engineer and a post-graduate Industrial Engineer from India, Sanat started his career with Hoechst Pharmaceuticals in 1983 and worked in many senior leadership assignments in 5 countries across 3 continents, rising to the level of Senior Vice President, Product Development & Supply at Aventis where he led global supply chain, including new product commercialization, technology and engineering.